The only thing? I doubt that would have any real impact at all.
The issue is more likely to be the complete lack of any traction. When I first invested in 2021, there were apparent pipelines to imminent deals with major hospitals around the world for 100,000s of licences.
Fast forward to August 2024 and we have about 600 people actively using it.
The CEO could buy on market every day and I doubt we'd stop sliding, let alone increase in value.
Ann: Quarterly Activities & Cashflow Report, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
